FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2013582472> ?p ?o ?g. }

• W2013582472 endingPage "1" @default.
• W2013582472 startingPage "1" @default.
• W2013582472 abstract "Efficacy and tolerability of a single-pill combination of telmisartan 80 mg and hydrochlorothiazide 25 mg according to age, gender, race, hypertension severity, and previous antihypertensive use: planned analyses of a randomized trial Dingliang Zhu,1 Harold Bays,2 Pingjin Gao,1 Michaela Mattheus,3 Birgit Voelker,3 Luis M Ruilope4 1Shanghai Ruijin Hospital, Shanghai, People’s Republic of China; 2Louisville Metabolic and Atherosclerosis Research Center Inc, Louisville, KY, USA; 3Boehringer Ingelheim International GmbH, Ingelheim, Germany; 4Hospital 12 de Octubre, Madrid, Spain Background: The purpose of this work was to describe the efficacy and safety of a telmisartan 80 mg + hydrochlorothiazide 25 mg (T80/H25) single-pill combination therapy in patients with moderate-severe hypertension (mean seated trough cuff systolic blood pressure [BP] ≥ 160 mmHg and diastolic BP ≥ 100 mmHg) in specific patient subpopulations. Methods: This was a planned analysis of a double-blind, multicenter, parallel-group trial that demonstrated the superiority of a single-pill combination of T80/H25 versus T80 monotherapy in terms of systolic BP change from baseline to week 7. Subpopulations included older (aged ≥ 65 years) versus younger, gender, race, hypertension severity, and prior antihypertensive therapy. Endpoints were change from baseline in mean seated trough cuff systolic and diastolic BP, proportion of patients achieving their BP goal (systolic/diastolic BP < 140/90 mmHg), and proportion of patients attaining systolic BP reductions of >30 mmHg and >40 mmHg. Results: Across all subgroups, the T80/H25 single-pill combination provided consistently greater systolic and diastolic BP reductions than T80 and more patients had systolic BP reductions of >30 mmHg. In the T80 and T80/H25 groups, BP control was achieved in 34.1% and 48.8% of men, 35.5% and 62.7% of women, 34.5% and 56.6% of Asians, 22.6% and 38.6% of blacks, 36.7% and 57.8% of whites, 36.9% and 57.5% of patients < 65 years, 29.3% and 49.3% ≥65 years, 44.2% and 66.2% of those with grade 2 hypertension, 20.4% and 39.4% of those with grade 3 hypertension, 38.9% and 53.2% of previously untreated patients, 38.1% and 62.5% of patients previously treated with one antihypertensive, and 29.7% and 48.9% of patients previously treated with two or more antihypertensive agents respectively. Treatment was generally well tolerated across the patient subgroups. Conclusion: The T80/H25 single-pill combination provides consistent BP reductions and higher goal attainment rates versus T80 across a range of hypertensive patient subgroups, which are likely to have a positive impact on patients’ cardiovascular risk. Keywords: grade 2 and 3 hypertension, age, race, gender, telmisartan, hydrochlorothiazide" @default.
• W2013582472 created "2016-06-24" @default.
• W2013582472 creator A5019931026 @default.
• W2013582472 creator A5053191013 @default.
• W2013582472 creator A5063579455 @default.
• W2013582472 creator A5079542540 @default.
• W2013582472 creator A5081837566 @default.
• W2013582472 creator A5085014810 @default.
• W2013582472 date "2013-04-01" @default.
• W2013582472 modified "2023-09-27" @default.
• W2013582472 title "Efficacy and tolerability of a single-pill combination of telmisartan 80 mg and hydrochlorothiazide 25 mg according to age, gender, race, hypertension severity, and previous antihypertensive use: planned analyses of a randomized trial" @default.
• W2013582472 cites W1554142330 @default.
• W2013582472 cites W1973763650 @default.
• W2013582472 cites W1988885266 @default.
• W2013582472 cites W2001595825 @default.
• W2013582472 cites W2006478907 @default.
• W2013582472 cites W2017942611 @default.
• W2013582472 cites W2033299396 @default.
• W2013582472 cites W2038299461 @default.
• W2013582472 cites W2038498871 @default.
• W2013582472 cites W2048043818 @default.
• W2013582472 cites W2058159909 @default.
• W2013582472 cites W2076929400 @default.
• W2013582472 cites W2095021588 @default.
• W2013582472 cites W2103943763 @default.
• W2013582472 cites W2126616478 @default.
• W2013582472 cites W2130530500 @default.
• W2013582472 cites W2133132829 @default.
• W2013582472 cites W2133497763 @default.
• W2013582472 cites W2140449653 @default.
• W2013582472 cites W2143954917 @default.
• W2013582472 cites W2148025183 @default.
• W2013582472 cites W2150286142 @default.
• W2013582472 cites W2156121263 @default.
• W2013582472 cites W2157267479 @default.
• W2013582472 cites W2158933938 @default.
• W2013582472 cites W2164437045 @default.
• W2013582472 cites W2167557672 @default.
• W2013582472 cites W2303651371 @default.
• W2013582472 cites W2106162949 @default.
• W2013582472 doi "https://doi.org/10.2147/ibpc.s33104" @default.
• W2013582472 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3636767" @default.
• W2013582472 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23637556" @default.
• W2013582472 hasPublicationYear "2013" @default.
• W2013582472 type Work @default.
• W2013582472 sameAs 2013582472 @default.
• W2013582472 citedByCount "6" @default.
• W2013582472 countsByYear W20135824722013 @default.
• W2013582472 countsByYear W20135824722016 @default.
• W2013582472 countsByYear W20135824722019 @default.
• W2013582472 countsByYear W20135824722022 @default.
• W2013582472 crossrefType "journal-article" @default.
• W2013582472 hasAuthorship W2013582472A5019931026 @default.
• W2013582472 hasAuthorship W2013582472A5053191013 @default.
• W2013582472 hasAuthorship W2013582472A5063579455 @default.
• W2013582472 hasAuthorship W2013582472A5079542540 @default.
• W2013582472 hasAuthorship W2013582472A5081837566 @default.
• W2013582472 hasAuthorship W2013582472A5085014810 @default.
• W2013582472 hasBestOaLocation W20135824721 @default.
• W2013582472 hasConcept C126322002 @default.
• W2013582472 hasConcept C164705383 @default.
• W2013582472 hasConcept C168563851 @default.
• W2013582472 hasConcept C197934379 @default.
• W2013582472 hasConcept C2778375690 @default.
• W2013582472 hasConcept C2779716603 @default.
• W2013582472 hasConcept C2780361556 @default.
• W2013582472 hasConcept C57900726 @default.
• W2013582472 hasConcept C71924100 @default.
• W2013582472 hasConcept C81603835 @default.
• W2013582472 hasConcept C84393581 @default.
• W2013582472 hasConcept C98274493 @default.
• W2013582472 hasConceptScore W2013582472C126322002 @default.
• W2013582472 hasConceptScore W2013582472C164705383 @default.
• W2013582472 hasConceptScore W2013582472C168563851 @default.
• W2013582472 hasConceptScore W2013582472C197934379 @default.
• W2013582472 hasConceptScore W2013582472C2778375690 @default.
• W2013582472 hasConceptScore W2013582472C2779716603 @default.
• W2013582472 hasConceptScore W2013582472C2780361556 @default.
• W2013582472 hasConceptScore W2013582472C57900726 @default.
• W2013582472 hasConceptScore W2013582472C71924100 @default.
• W2013582472 hasConceptScore W2013582472C81603835 @default.
• W2013582472 hasConceptScore W2013582472C84393581 @default.
• W2013582472 hasConceptScore W2013582472C98274493 @default.
• W2013582472 hasLocation W20135824721 @default.
• W2013582472 hasLocation W20135824722 @default.
• W2013582472 hasLocation W20135824723 @default.
• W2013582472 hasLocation W20135824724 @default.
• W2013582472 hasLocation W20135824725 @default.
• W2013582472 hasOpenAccess W2013582472 @default.
• W2013582472 hasPrimaryLocation W20135824721 @default.
• W2013582472 hasRelatedWork W1213622947 @default.
• W2013582472 hasRelatedWork W141220594 @default.
• W2013582472 hasRelatedWork W1966234202 @default.
• W2013582472 hasRelatedWork W2124770238 @default.
• W2013582472 hasRelatedWork W2257778314 @default.
• W2013582472 hasRelatedWork W2370961017 @default.
• W2013582472 hasRelatedWork W2411887466 @default.
• W2013582472 hasRelatedWork W2774395011 @default.

• next